SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-000019
Filing Date
2024-01-02
Accepted
2024-01-02 08:10:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20017824x1_defa14a.htm DEFA14A 18351
2 ny20017824x1_stlogo.jpg GRAPHIC 4736
  Complete submission text file 0001140361-24-000019.txt   26232
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22245 | Film No.: 24500339
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)